Placental site trophoblastic tumor: Clinical and pathological report of two cases

G. Arató, V. Fülöp, P. Degrell, I. Szigetvári

Research output: Article

13 Citations (Scopus)

Abstract

Placental site trophoblastic tumor (PSTT) is the rarest disease of the gestational trophoblast. Our two cases will be interesting not only because of the rarity of the disease, but because both were recognized before operation. Since the tumor cells are lined up tightly side by side, this disease must be distinguished primarily from tumors of epithelial origin. The authors highlight that the diagnosis should rely on intense hPL-positivity as well as the ultrastructural image of the tumor. In histologically equivocal cases, the determination of hPL, hCG, and MIB-1 immunologic markers can be recommended as routinely performed morphological examinations. Serum hCG monitoring is recommended to follow the evolution of the tumor.

Original languageEnglish
Pages (from-to)292-294
Number of pages3
JournalPathology and Oncology Research
Volume6
Issue number4
Publication statusPublished - 2000

Fingerprint

Placental Site Trophoblastic Tumor
Neoplasms
Trophoblasts
Rare Diseases
Biomarkers
Serum

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pathology and Forensic Medicine

Cite this

Placental site trophoblastic tumor : Clinical and pathological report of two cases. / Arató, G.; Fülöp, V.; Degrell, P.; Szigetvári, I.

In: Pathology and Oncology Research, Vol. 6, No. 4, 2000, p. 292-294.

Research output: Article

Arató, G. ; Fülöp, V. ; Degrell, P. ; Szigetvári, I. / Placental site trophoblastic tumor : Clinical and pathological report of two cases. In: Pathology and Oncology Research. 2000 ; Vol. 6, No. 4. pp. 292-294.
@article{35c9b0b41d4c4c5b96dc81af4e518ade,
title = "Placental site trophoblastic tumor: Clinical and pathological report of two cases",
abstract = "Placental site trophoblastic tumor (PSTT) is the rarest disease of the gestational trophoblast. Our two cases will be interesting not only because of the rarity of the disease, but because both were recognized before operation. Since the tumor cells are lined up tightly side by side, this disease must be distinguished primarily from tumors of epithelial origin. The authors highlight that the diagnosis should rely on intense hPL-positivity as well as the ultrastructural image of the tumor. In histologically equivocal cases, the determination of hPL, hCG, and MIB-1 immunologic markers can be recommended as routinely performed morphological examinations. Serum hCG monitoring is recommended to follow the evolution of the tumor.",
keywords = "Choriocarcinoma, Immunohistology, Intermediate trophoblast, Placental trophoblastic tumor",
author = "G. Arat{\'o} and V. F{\"u}l{\"o}p and P. Degrell and I. Szigetv{\'a}ri",
year = "2000",
language = "English",
volume = "6",
pages = "292--294",
journal = "Pathology and Oncology Research",
issn = "1219-4956",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Placental site trophoblastic tumor

T2 - Clinical and pathological report of two cases

AU - Arató, G.

AU - Fülöp, V.

AU - Degrell, P.

AU - Szigetvári, I.

PY - 2000

Y1 - 2000

N2 - Placental site trophoblastic tumor (PSTT) is the rarest disease of the gestational trophoblast. Our two cases will be interesting not only because of the rarity of the disease, but because both were recognized before operation. Since the tumor cells are lined up tightly side by side, this disease must be distinguished primarily from tumors of epithelial origin. The authors highlight that the diagnosis should rely on intense hPL-positivity as well as the ultrastructural image of the tumor. In histologically equivocal cases, the determination of hPL, hCG, and MIB-1 immunologic markers can be recommended as routinely performed morphological examinations. Serum hCG monitoring is recommended to follow the evolution of the tumor.

AB - Placental site trophoblastic tumor (PSTT) is the rarest disease of the gestational trophoblast. Our two cases will be interesting not only because of the rarity of the disease, but because both were recognized before operation. Since the tumor cells are lined up tightly side by side, this disease must be distinguished primarily from tumors of epithelial origin. The authors highlight that the diagnosis should rely on intense hPL-positivity as well as the ultrastructural image of the tumor. In histologically equivocal cases, the determination of hPL, hCG, and MIB-1 immunologic markers can be recommended as routinely performed morphological examinations. Serum hCG monitoring is recommended to follow the evolution of the tumor.

KW - Choriocarcinoma

KW - Immunohistology

KW - Intermediate trophoblast

KW - Placental trophoblastic tumor

UR - http://www.scopus.com/inward/record.url?scp=0034473138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034473138&partnerID=8YFLogxK

M3 - Article

C2 - 11173663

AN - SCOPUS:0034473138

VL - 6

SP - 292

EP - 294

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

SN - 1219-4956

IS - 4

ER -